BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2384651)

  • 1. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.
    Tal A; Aviram M; Gorodischer R
    J Allergy Clin Immunol; 1990 Aug; 86(2):238-43. PubMed ID: 2384651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma.
    Aviram M; Tal A; Ben-Zvi Z; Gorodischer R
    Pediatrics; 1987 Dec; 80(6):894-7. PubMed ID: 3684402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E; Baba M
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of theophylline chronokinetics for asthmatic children.
    Smolensky MH; Scott PH; McGovern JP
    Prog Clin Biol Res; 1987; 227B():259-70. PubMed ID: 3628336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
    Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
    Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sustained-release theophylline: study in a child population].
    Díaz Fernández M; Gracía Hidalgo A; Mateo Cañas G; López Elorze F
    An Esp Pediatr; 1986 Jan; 24(1):7-13. PubMed ID: 3963648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
    Trnavská Z; Vondra V; Elis J
    Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
    Boner AL; Sette L; Vallone G; Plebani M; Messori A
    Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Compliance of children with bronchial asthma in long-term therapy with theophylline retard preparations].
    Köhler E; Sollich V; Schuster R
    Kinderarztl Prax; 1993 Aug; 61(6):207-10. PubMed ID: 8411846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary theophylline monitoring in asthmatic children.
    Orłowski L; Paczkowski D; Podleśny J
    Pol J Pharmacol Pharm; 1987; 39(2):173-6. PubMed ID: 3432165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of theophylline treatment by saliva and plasma concentrations.
    Juntunen-Backman K; Backman A; Björkstén F; Finnilä MJ
    Allergol Immunopathol (Madr); 1988; 16(1):5-9. PubMed ID: 3381714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
    D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger HW; Sauter R; Steinijans VW
    Pneumologie; 1991 Nov; 45 Suppl 4():834-41. PubMed ID: 1812476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of salivary with serum levels of retard theophylline under steady-state conditions].
    Virchow C; Schmitz-Schumann M; Mansfeld J
    Pneumologie; 1990 Feb; 44 Suppl 1():281-2. PubMed ID: 2367390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
    Liebke C; Niggemann B; Wahn U
    Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between plasma and stimulated-saliva concentrations of theophylline in asthmatic children.
    Krivoy N; Zinman P; Hoffer E; Teitelman U; Rubin A
    Pharmatherapeutica; 1985; 4(5):285-7. PubMed ID: 4070321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring long-term therapy with theophylline preparations in children with asthma].
    Lindemann H; Bauer J; Schwandt HJ
    Monatsschr Kinderheilkd; 1985 Feb; 133(2):106-10. PubMed ID: 3920513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
    Raj NS; Guleria R; Misra A; Pande JN
    Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained-release theophylline therapy for chronic childhood asthma.
    Bell T; Bigley J
    Pediatrics; 1978 Sep; 62(3):352-8. PubMed ID: 704210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics and chronotherapy of delayed action theophylline (Euphyllin CR)].
    Vondra V; Spicák V; Trnavská Z; Reisová M; Pohunek P; Tomíska F
    Cas Lek Cesk; 1989 May; 128(19):595-8. PubMed ID: 2743384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.